Design of Hybrid Molecules for Drug Development, 1e
by Michael Decker
- Paperback: 352 pages
- Publisher: Elsevier; 1 edition (April 25, 2017)
- Language: English
- ISBN-10: 0081010117
- ISBN-13: 978-0081010112
- Amazon Price: $199.50
- Points to download: 100 Points
- Format: Original Publisher PDF
- File Size: 15.8 MB
- Download link below.
This post contains protected content. You must be logged in and have 100 points to unlock it.
Design of Hybrid Molecules for Drug Development reviews the principles, advantages, and limitations involved with designing these groundbreaking compounds. Beginning with an introduction to hybrid molecule design and background as to their need, the book goes on to explore a range of important hybrids, with hybrids containing natural products, molecules containing NO- and H2S-donors, dual-acting compounds acting as receptor ligands and enzyme inhibitors, and the design of photoresponsive drugs all discussed. Drawing on practical case studies, the hybridization of molecules for development as treatments for a number of key diseases is then outlined, including the design of hybrids for Alzheimer’s, cancer, and malaria. With its cutting-edge reviews of breaking developments in this exciting field, the book offers a novel approach for all those working in the design, development, and administration of drugs for a range of debilitating disorders.Highlights an approach unimpaired by the limitations of the classical search for lead structures – one of the core problems in modern drug development processes, making the content of high relevance for both academic and non-academic drug development processesPulls together research and design techniques in a novel way to give researchers the best possible platform from which to review the approaches and techniques appliedCompares the advantages and disadvantages of these compoundsIncludes the very latest developments, such as photoactivatable and photo-responsive drugs